miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation
Silvia Moimas(Zero to Three), Marco Confalonieri(University of Trieste)
Cited by 59
Related Papers
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
|Pharmaceuticals|2024|86
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
|Pharmaceuticals|2025|6
Comorbidities’ Effect on IPF: Pathogenesis and Management
|Biomedicines|2025|3